NCT00611351 2023-10-23Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic CancerUniversity of NebraskaPhase 2 Completed5 enrolled 10 charts
NCT00949052 2018-08-16Genetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for CancerVanderbilt-Ingram Cancer CenterTerminated1,000 enrolled